Independence Day 2022: These 7 Indian companies, formed before Independence are making huge impact around globe
As India is commemorating its 75 Independence Day, here's looking at top 7 Indian MNCs born before Independence. These companies, other than giving livelihood to millions of people, are also playing a big role in raising the country's pride around the globe.
Aug 09, 2022, 13:23 PM IST
Cipla promoters sell shares worth over Rs 1,835 crore
After this transaction, the promoter group will continue to hold 34.23 per cent in the company, it added.
Feb 15, 2022, 22:30 PM IST
5 Indian pharma companies would jointly conduct a clinical trial of COVID drug
They would carry out a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in India
Jun 29, 2021, 17:32 PM IST
Vaccine no. 4 is almost here, Cipla gets nod to import Moderna jab
Pharmaceutical company Cipla has now got Drugs Controller General of India’s (DCGI) nod to import Moderna's COVID-19 vaccine for restricted emergency use in India, say sources
Jun 29, 2021, 15:37 PM IST
Scrutinise roles of MLA Zeeshan Siddique, Sonu Sood in procuring anti-COVID drugs for people: HC to Maha
The high court also observed that "these people (celebrities) projected themselves as some kind of messiahs without verifying if the drugs were spurious or if the supply was legal".
Jun 16, 2021, 17:21 PM IST
What is an antibody cocktail, is it effective against COVID-19, Zee explains
While vaccination continues to play a major role in combating the COVID-19 virus, doctors across the world have been using various other innovative medical techniques, therapies to treat coronavirus patients.
May 28, 2021, 16:03 PM IST
Moderna to launch single-dose COVID-19 vaccine in India in 2022, Pfizer ready to offer 5 crore doses this year
Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday.
May 26, 2021, 06:43 AM IST
Roche, Cipla launch ‘Antibody Cocktail’ for treatment of mild to moderate COVID-19
Priced at Rs 59,750 per dose, the medicine consists of an amalgamation of Casirivimab and Imdevimab drugs. Cipla will take care of the distribution of the product.
May 24, 2021, 15:36 PM IST
Cipla witnesses 3 senior-level exits including India biz CEO
Chopra joined the company in 1996 and has served in various leadership positions across India.
Aug 04, 2020, 18:03 PM IST
Glenmark, Cipla stocks surge after nod to launch drugs for COVID-19
The Nifty pharma index was trading higher by 2.62 percent at 10264.45 at 2.41 pm.
Jun 22, 2020, 14:46 PM IST
IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit
The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE. The move is a part of Asia Index's semi-annual reconstitution results.
Nov 17, 2017, 21:00 PM IST
Indian equities trade flat with marginal losses, healthcare stocks slip
On Thursday, weak services sector data and heavy selling pressure in banking and metal stocks dragged the benchmark indices lower.
Cancer drug: SC allows Cipla to withdraw appeal against Roche
The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.
Jun 16, 2017, 15:18 PM IST
Investor wealth surges over Rs 50 lakh crore in 3 years
Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.
May 26, 2017, 18:08 PM IST
Cipla shares down 3%; mcap dips Rs 1,003 crore post Q4 results
Shares of pharma major Cipla on Friday fell by 3 percent after the company reported a consolidated net loss of Rs 61.79 crore for the March quarter.
May 26, 2017, 18:04 PM IST
Cipla gets USFDA nod for generic HIV drug
Cipla has received approval from the US health regulator for its generic Abacavir and Lamivudine tablets used for treatment of HIV infection.
Apr 04, 2017, 15:14 PM IST
634 drugs on NPPA's price ceiling non-compliant list
As many as 634 drugs of various strengths produced by firms, including Cipla, Abbott, Astrazeneca and Dr Reddy's, are "suspected" to be non-compliant with ceiling prices as notified by NPPA.
Feb 23, 2017, 23:33 PM IST
Cipla initiates campaign for a pollution free Delhi; starts #saveyourlungsdilli
According to a TGI Survey, 34 percent (approx five million) of Delhi people are suffering respiratory problems including Asthma, Bronchitis, and Chronic Obstructive Pulmonary Disease.
Jan 19, 2017, 20:33 PM IST
Cipla appoints Ireena Vittal as independent director
Drug major Cipla on Tuesday said it has appointed Ireena Vittal as an independent director on its board with effect from December 1, 2016.
Nov 29, 2016, 13:48 PM IST
Cipla gets four USFDA observations for three Goa facilities; stocks fall over 3%
Drug firm Cipla on Friday said the US health regulator has issued four observations across its three manufacturing facilities in Goa after the inspection.
Sep 30, 2016, 14:30 PM IST
